Metabolic Syndrome and Elevated C-Reactive Protein Levels in Elderly Patients With Newly Diagnosed Depression

Psychosomatics

Volumn 55, Issue 6, 2014, Pages 640-649

  Park, Soyeon ^a   Joo, Yeon Ho ^a   McIntyre, Roger S ^b   Kim, Byungsu ^a,c  

^a University of Ulsan College of Medicine   (South Korea)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

AGED; ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; INFLAMMATION; LIFESTYLE; MAJOR DEPRESSION; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; PHYSICIAN; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; CASE CONTROL STUDY; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; RISK FACTOR; SOCIOECONOMICS;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS; WAIST CIRCUMFERENCE;

EID: 84926419027     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2013.12.010     Document Type: Article

References (72)

1. Luppa M., Sikorski C., Luck T., et al. Age- and gender-specific prevalence of depression in latest-life-systematic review and meta-analysis. J Affect Disord 2012, 136(3):212-221.
2. Kupfer D.J., Frank E., Phillips M.L. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012, 379(9820):1045-1055.
3. Van der Kooy K., van Hout H., Marwijk H., Marten H., Stehouwer C., Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 2007, 22(7):613-626.
4. Meijer A., Conradi H.J., Bos E.H., Thombs B.D., van Melle J.P., de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011, 33(3):203-216.
5. Thombs B.D., Bass E.B., Ford D.E., et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006, 21(1):30-38.
6. Newson R.S., Hek K., Luijendijk H.J., Hofman A., Witteman J.C., Tiemeier H. Atherosclerosis and incident depression in late life. Arch Gen Psychiatry 2010, 67(11):1144-1151.
7. Osby U., Brandt L., Correia N., Ekbom A., Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001, 58(9):844-850.
8. Teixeira P.J., Rocha F.L. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr 2007, 29(4):330-336.
9. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 2002, 287(3):356-359.
10. Pan A., Keum N., Okereke O.I., et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012, 35(5):1171-1180.
11. Kahl K.G., Greggersen W., Schweiger U., et al. Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci 2012, 262(4):313-320.
12. Pyykkonen A.J., Raikkonen K., Tuomi T., Eriksson J.G., Groop L., Isomaa B. Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med 2012, 44(3):279-288.
13. Hildrum B., Mykletun A., Midthjell K., Ismail K., Dahl A.A. No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study. Acta Psychiatr Scand 2009, 120(1):14-22.
14. Herva A., Rasanen P., Miettunen J., et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study. Psychosom Med 2006, 68(2):213-216.
15. Gans R.O. The metabolic syndrome, depression, and cardiovascular disease: interrelated conditions that share pathophysiologic mechanisms. Med Clin North Am 2006, 90(4):573-591.
16. Denys K., Cankurtaran M., Janssens W., Petrovic M. Metabolic syndrome in the elderly: an overview of the evidence. Acta Clin Belg 2008, 64(1):23-34.
17. Liu M., Wang J., Jiang B., et al. Increasing prevalence of metabolic syndrome in a Chinese elderly population: 2001-2010. PLoS One 2013, 8(6):e66233.
18. Vogelzangs N., Beekman A.T., Boelhouwer I.G., et al. Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons. J Clin Psychiatry 2011, 72(5):598-604.
19. Bove M., Carnevali L., Cicero A.F., et al. Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project. Aging Ment Health 2010, 14(7):801-806.
20. Morikawa M., Okamoto N., Kiuchi K., et al. Association between depressive symptoms and metabolic syndrome in Japanese community-dwelling older people: a cross-sectional analysis from the baseline results of the Fujiwara-kyo prospective cohort study. Int J Geriatr Psychiatry 2013, 28(12):1251-1259.
21. Akbaraly T.N., Ancelin M.L., Jaussent I., et al. Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Diabetes Care 2011, 34(4):904-909.
22. Vogelzangs N., Beekman A.T., Dik M.G., et al. Late-life depression, cortisol, and the metabolic syndrome. Am J Geriatr Psychiatry 2009, 17(8):716-721.
23. Singh T., Newman A.B. Inflammatory markers in population studies of aging. Ageing Res Rev 2011, 10(3):319-329.
24. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342(12):836-843.
25. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71(2):171-186.
26. Penninx B.W., Kritchevsky S.B., Yaffe K., et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003, 54(5):566-572.
27. Ladwig K.H., Marten-Mittag B., Lowel H., Doring A., Koenig W. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav Immun 2003, 17(4):268-275.
28. Hamer M., Molloy G.J., de Oliveira C., Demakakos P. Persistent depressive symptomatology and inflammation: to what extent do health behaviours and weight control mediate this relationship?. Brain Behav Immun 2009, 23(4):413-418.
29. Elovainio M, Keltikangas-Jarvinen L, et al: Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psychol Med 2006; 36(6):797-805.
30. Viscogliosi G., Andreozzi P., Chiriac I.M., et al. Depressive symptoms in older people with metabolic syndrome: is there a relationship with inflammation?. Int J Geriatr Psychiatry 2013, 28(3):242-247.
31. Laudisio A., Marzetti E., Pagano F., Pozzi G., Bernabei R., Zuccala G. Depressive symptoms and metabolic syndrome: selective association in older women. J Geriatr Psychiatry Neurol 2009, 22(4):215-222.
32. Danese A., Moffitt T.E., Harrington H., et al. Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med 2009, 163(12):1135-1143.
33. Leonard B.E. Inflammation as the cause of the metabolic syndrome in depression. Mod Trends Pharmacopsychiatry 2013, 28:117-126.
34. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645.
35. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23(5):469-480.
36. Lee E.S., Oh S.W., Yoon Y.S. Metabolic syndrome defined by International Diabetes Federation (IDF) or National Cholesterol Education Program (NCEP) and insulin resistance. Korean J Obes 2006, 15(2):91-97.
37. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3):499-511.
38. Vogelzangs N., Suthers K., Ferrucci L., et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 2007, 32(2):151-159.
39. Vaccarino V., McClure C., Johnson B.D., et al. Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med 2008, 70(1):40-48.
40. Almeida O.P., Calver J., Jamrozik K., Hankey G.J., Flicker L. Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 2009, 17(10):889-898.
41. Takeuchi T., Nakao M., Nomura K., et al. Association of the metabolic syndrome with depression and anxiety in Japanese men: a 1-year cohort study. Diabetes Metab Res Rev 2009, 25(8):762-767.
42. Akbaraly T.N., Kivimaki M., Brunner E.J., et al. Association between metabolic syndrome and depressive symptoms in middle-aged adults results from the Whitehall II study. Diabetes Care 2009, 32(3):499-504.
43. Carpiniello B., Pinna F., Velluzzi F., Loviselli A. Mental disorders in patients with metabolic syndrome. The key role of central obesity. Eat Weight Disord 2012, 17(4):e259-e266.
44. Gil K., Radzillowicz P., Zdrojewski T., et al. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project. Kardiol Pol 2006, 64(5):464-469.
45. Wong S.Y., Leung J.C., Leung P.C., Woo J. Depressive symptoms and change in abdominal obesity in the elderly: positive or negative association?. Am J Geriatr Psychiatry 2011, 19(8):730-742.
46. Carr D.B., Utzschneider K.M., Hull R.L., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004, 53(8):2087-2094.
47. Vogelzangs N., Kritchevsky S.B., Beekman A.T., et al. Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 2008, 65(12):1386-1393.
48. Vogelzangs N., Kritchevsky S.B., Beekman A.T., et al. Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J Clin Psychiatry 2010, 71(4):391-399.
49. Zhao G., Ford E., Li C., Tsai J., Dhingra S., Balluz L. Waist circumference, abdominal obesity, and depression among overweight and obese US adults: national health and nutrition examination survey 2005-2006. BMC Psychiatry 2011, 11(1):130.
50. Kop W.J., Gottdiener J.S., Tangen C.M., et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002, 89(4):419-424.
51. Pasco J.A., Nicholson G.C., Williams L.J., et al. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 2010, 197(5):372-377.
52. Almeida O.P., Norman P., Hankey G.J., Jamrozik K., Flicker L. The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in Men Study (HIMS). Psychol Med 2007, 37(12):1775-1786.
53. van den Biggelaar A.H., Gussekloo J., de Craen A.J., et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 2007, 42(7):693-701.
54. Luukinen H., Jokelainen J., Hedberg P. The relationships between high-sensitivity C-reactive protein and incident depressed mood among older adults. Scand J Clin Lab Invest 2010, 70(2):75-79.
55. Arbelaez J.J., Ariyo A.A., Crum R.M., Fried L.P., Ford D.E. Depressive symptoms, inflammation, and ischemic stroke in older adults: a prospective analysis in the cardiovascular health study. J Am Geriatr Soc 2007, 55(11):1825-1830.
56. Elovainio M., Aalto A.M., Kivimaki M., et al. Depression and C-reactive protein: population-based Health 2000 Study. Psychosom Med 2009, 71(4):423-430.
57. Copeland W.E., Shanahan L., Worthman C., Angold A., Costello E.J. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry 2012, 71(1):15-21.
58. Zahn D., Petrak F., Uhl I., et al. New pathways of increased cardiovascular risk in depression: a pilot study on the association of high-sensitivity C-reactive protein with pro-atherosclerotic markers in patients with depression. J Affect Disord 2013, 146(3):420-425.
59. Hamer M., Malan N.T., Harvey B.H., Malan L. Depressive symptoms and sub-clinical atherosclerosis in Africans: role of metabolic syndrome, inflammation and sympathoadrenal function. Physiol Behav 2011, 104(5):744-748.
60. Capuron L., Su S., Miller A.H., et al. Depressive symptoms and metabolic syndrome: is inflammation the underlying link?. Biol Psychiatry 2008, 64(10):896-900.
61. Valtonen M.K., Laaksonen D.E., Laukkanen J.A., et al. Low-grade inflammation and depressive symptoms as predictors of abdominal obesity. Scand J Public Health 2012, 40(7):674-680.
62. Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112(12):1821-1830.
63. Tilg H., Moschen A.R. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008, 14(3-4):222-231.
64. Halaris A. Co-Morbidity between cardiovascular pathology and depression: role of inflammation. Mod Trends Pharmacopsychiatry 2013, 28:144-161.
65. Chen Y.C., Lin W.W., Chen Y.J., Mao W.C., Hung Y.J. Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males. Mediators Inflamm 2010, 2010:573594.
66. van Reedt Dortland A.K., Giltay E.J., van Veen T., Zitman F.G., Penninx B.W. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 2010, 122(1):30-39.
67. Horacek J., Kuzmiakova M., Hoschl C., Andel M., Bahbonh R. The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers. Psychoneuroendocrinology 1999, 24(8):785-797.
68. Potter van Loon B.J., Radder J.K., Frolich M., Krans H.M., Zwinderman A.H., Meinders A.E. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes Relat Metab Disord 1992, 16(2):79-85.
69. Goodnick P.J., Henry J.H., Buki V.M. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995, 56(4):128-136.
70. Kauffman R.P., Castracane V.D., White D.L., Baldock S.D., Owens R. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age. Gynecol Endocrinol 2005, 21(3):129-137.
71. Taylor V., McKinnon M.C., Macdonald K., Jaswal G., Macqueen G.M. Adults with mood disorders have an increased risk profile for cardiovascular disease within the first 2 years of treatment. Can J Psychiatry 2010, 55(6):362-368.
72. Mottillo S., Filion K.B., Genest J., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56(14):1113-1132.